Search Results

Filter
  • 1-10 of  1,390 results for ""Kidney drug effects""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

In vivo liposomal delivery of PPARα/γ dual agonist tesaglitazar in a model of obesity enriches macrophage targeting and limits liver and kidney drug effects.

  • Authors : Osinski V; Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia, 22908, USA.; Department of Pathology, University of Virginia, Charlottesville, VA, 22908, USA.

Subjects: Alkanesulfonates/Alkanesulfonates/Alkanesulfonates/*pharmacology ; Kidney/Kidney/Kidney/*drug effects ; Liposomes/Liposomes/Liposomes/*administration & dosage

  • Source: Theranostics [Theranostics] 2020 Jan 01; Vol. 10 (2), pp. 585-601. Date of Electronic Publication: 2020 Jan 01 (Print Publication: 2020).Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-10 of  1,390 results for ""Kidney drug effects""